Cubist Systematic Strategies, LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2023$246,302
+938.2%
133,860
+972.0%
0.00%
Q4 2022$23,725
-12.1%
12,487
-1.0%
0.00%
Q3 2022$27,000
-55.7%
12,618
-41.3%
0.00%
Q2 2022$61,000
-56.1%
21,487
-20.0%
0.00%
-100.0%
Q4 2021$139,000
+3.7%
26,854
+32.7%
0.00%
-50.0%
Q2 2021$134,000
-10.1%
20,244
-22.1%
0.00%0.0%
Q1 2021$149,000
+14800.0%
25,974
+10501.6%
0.00%
Q1 2020$1,0000.0%245
+188.2%
0.00%
Q4 2019$1,000850.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders